Acute Intravenous l -Arginine Infusion Decreases Endothelin-1 Levels and Improves Endothelial Function in Patients With Angina Pectoris and Normal Coronary Arteriograms
- 28 January 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (3) , 429-436
- https://doi.org/10.1161/01.cir.0000046489.24563.79
Abstract
Background— We tested the hypothesis that asymmetric dimethylarginine (ADMA) levels could be elevated and influence endothelin-1 and nitric oxide release and action in patients with cardiac syndrome X (CSX). In addition, we evaluated whether an intravenous infusion of l-arginine would improve endothelial function in these subjects.Keywords
This publication has 31 references indexed in Scilit:
- The vascular effects of L-Arginine in humans. The role of endogenous insulin.Journal of Clinical Investigation, 1997
- Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.Journal of Clinical Investigation, 1996
- Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms.Heart, 1995
- Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.Journal of Clinical Investigation, 1992
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginineThe Lancet, 1991
- Increased Plasma Endothelin Level in Patients with Essential HypertensionNew England Journal of Medicine, 1990
- INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1989
- Binding and receptor down‐regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cellsFEBS Letters, 1988
- The Endothelium — Modulator of Vascular Smooth-Muscle ToneNew England Journal of Medicine, 1988